BACKGROUND:Children undergoinghematopoietic stem cell transplantation (HSCT) often require parenteral nutrition (PN) to optimize caloric intake. Standard approaches to nutritional supplementation provide 130-150% of estimated energy expenditure, but resting energy expenditure (REE) may be lower than expected after HSCT. Provision of PN exceeding energy needs may lead to overfeeding and associated complications. OBJECTIVE: We conducted a blinded, randomized, controlled, multicenter trial in children undergoingHSCT to determine the effect on body composition of 2 different approaches of nutrition support: standard amounts of energy from PN (130-150% of REE) compared with PN titrated to match measured REE. DESIGN:Twenty-six children undergoing HSCT were randomly assigned to standard or titrated PN. Energy intake was monitored until day 30 after HSCT. Body-composition and anthropometric measures were obtained through day 100. The primary outcome variable was percentage body fat (%BF) measured by dual energy X-ray absorptiometry. RESULTS: The estimated change in %BF from baseline to day 30 was 1.2 ± 0.5% in the standard group and 0.1 ± 0.5% in the experimental group, but the overall time course of %BF did not differ significantly by treatment (P = 0.39 for time × treatment interaction). A profound loss of lean body mass (LBM) occurred in both groups during the intervention period and persisted through day 100. CONCLUSIONS: Parenteral energy intake titrated to energy expenditure does not result in a lower accumulation of BF than does standard energy intake. Neither titrated nor standard PN regimens during HSCT preserve LBM. Alternative approaches to preserve LBM are needed. This trial is registered at clinicaltrials.gov as 00115258.
RCT Entities:
BACKGROUND:Children undergoing hematopoietic stem cell transplantation (HSCT) often require parenteral nutrition (PN) to optimize caloric intake. Standard approaches to nutritional supplementation provide 130-150% of estimated energy expenditure, but resting energy expenditure (REE) may be lower than expected after HSCT. Provision of PN exceeding energy needs may lead to overfeeding and associated complications. OBJECTIVE: We conducted a blinded, randomized, controlled, multicenter trial in children undergoing HSCT to determine the effect on body composition of 2 different approaches of nutrition support: standard amounts of energy from PN (130-150% of REE) compared with PN titrated to match measured REE. DESIGN: Twenty-six children undergoing HSCT were randomly assigned to standard or titrated PN. Energy intake was monitored until day 30 after HSCT. Body-composition and anthropometric measures were obtained through day 100. The primary outcome variable was percentage body fat (%BF) measured by dual energy X-ray absorptiometry. RESULTS: The estimated change in %BF from baseline to day 30 was 1.2 ± 0.5% in the standard group and 0.1 ± 0.5% in the experimental group, but the overall time course of %BF did not differ significantly by treatment (P = 0.39 for time × treatment interaction). A profound loss of lean body mass (LBM) occurred in both groups during the intervention period and persisted through day 100. CONCLUSIONS: Parenteral energy intake titrated to energy expenditure does not result in a lower accumulation of BF than does standard energy intake. Neither titrated nor standard PN regimens during HSCT preserve LBM. Alternative approaches to preserve LBM are needed. This trial is registered at clinicaltrials.gov as 00115258.
Authors: V Chamouard Cogoluenhes; C Chambrier; M Michallet; B Gordiani; J Y Ranchere; D Combret; Y Lallemand; M Roldan; M Accominoti; I Philip; J F Latour; G Hulewitz; P Biron; A Barbieux; P Bachmann Journal: Clin Nutr Date: 1998-12 Impact factor: 7.324
Authors: Kristen A Neville; Richard J Cohn; Katharine S Steinbeck; Karen Johnston; Jan L Walker Journal: J Clin Endocrinol Metab Date: 2006-09-05 Impact factor: 5.958
Authors: Joanna L Perkins; Alicia S Kunin-Batson; Nancy M Youngren; Kirsten K Ness; Kami J Ulrich; Melissa J Hansen; Anna Petryk; Julia Steinberger; Fiona S Anderson; K Scott Baker Journal: Pediatr Blood Cancer Date: 2007-12 Impact factor: 3.167
Authors: Lori J Bechard; Eva C Guinan; Henry A Feldman; Vivian Tang; Christopher Duggan Journal: JPEN J Parenter Enteral Nutr Date: 2007 Jul-Aug Impact factor: 4.016
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079
Authors: Lori J Bechard; Catherine Gordon; Henry A Feldman; Robert Venick; Kathleen Gura; Eva C Guinan; Christopher Duggan Journal: Pediatr Blood Cancer Date: 2015-01-28 Impact factor: 3.167
Authors: Enid E Martinez; Craig D Smallwood; Nicolle L Quinn; Katelyn Ariagno; Lori J Bechard; Christopher P Duggan; Nilesh M Mehta Journal: J Pediatr Date: 2017-11 Impact factor: 4.406
Authors: Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan Journal: J Pediatr Gastroenterol Nutr Date: 2014-06 Impact factor: 2.839
Authors: L J Bechard; H A Feldman; R Venick; K Gura; C Gordon; A Sonis; N Mehta; E C Guinan; C Duggan Journal: Bone Marrow Transplant Date: 2012-02-20 Impact factor: 5.483